- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Nexalin Technology, Inc.: Nexalin Announces Peer-Reviewed Study Showing the Company's DIFS Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents | 1 | GlobeNewswire (USA) | ||
| Do | EXCLUSIVE: Nexalin Study Flags Reduced Self-Injury In Adolescents Using Brain Stimulation Device | 2 | Benzinga.com | ||
| 25.03. | Nexalin Technology, Inc. - 10-K, Annual Report | 3 | SEC Filings | ||
| 25.02. | Nexalin Technology, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 24.02. | Nexalin Technology, Inc.: Nexalin Announces Pivotal HALO Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market | 571 | GlobeNewswire (Europe) | 150-Patient, Triple-Blinded, Sham-Controlled Study Designed to be Executed in Collaboration with Lindus Health to Support Future FDA Submission for Drug-Free Insomnia Treatment Builds on Prior Peer-Reviewed... ► Artikel lesen | |
| 24.02. | EXCLUSIVE: Penny Stock Nexalin Advances Pivotal Trial Aiming To Tackle Severe Insomnia | 3 | Benzinga.com | ||
| 23.02. | Nexalin Technology, Inc.: Nexalin Participates in and Commends Recent Congressional Momentum Supporting Deep Brain Neurostimulation Research for Veterans and Neurological Disorders | 1 | GlobeNewswire (USA) | ||
| 13.02. | RedChip Companies, Inc.: Nexalin Technology and First Phosphate Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 926 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / February 13, 2026 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and First Phosphate Corp. (CSE:PHOS)(OTCQX:FRSPF)(FSE:KD0) on the... ► Artikel lesen | |
| NEXALIN TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 05.02. | Nexalin Technology, Inc.: Nexalin Launches NeuroCare, an AI-Driven Virtual Clinic Designed to Transform Access for Patients with Alzheimer's, Mood Disorders, TBI & PTSD Care | 2 | GlobeNewswire (USA) | ||
| 05.02. | EXCLUSIVE: Nexalin Launches AI-Powered Virtual Clinic For Brain Health For Home Settings | 1 | Benzinga.com | ||
| 02.02. | Nexalin reports brain imaging studies validate its neurostimulation tech | 1 | Investing.com | ||
| 02.02. | Nexalin Technology, Inc.: Nexalin Highlights its Expanding Body of Peer-Reviewed Neuroimaging Research Confirming its DIFS Technology as the Leader in Evidenced-Based Non-Invasive Brain Stimulation | 5 | GlobeNewswire (USA) | ||
| 23.01. | Nexalin erhält Rüge der NASDAQ wegen Nichterfüllung der Mindestkursanforderung | 2 | Investing.com Deutsch | ||
| 23.01. | Nexalin receives Nasdaq minimum bid price deficiency notice | 3 | Investing.com | ||
| 23.01. | Nexalin Technology receives Nasdaq bid price deficiency notice | 2 | Seeking Alpha | ||
| 23.01. | Nexalin Technology, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.01. | Nexalin Technology, Inc.: Nexalin Technology Receives Nasdaq Listing Status Notification | 223 | GlobeNewswire (Europe) | HOUSTON, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the "Company" or "Nexalin"), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS) of the... ► Artikel lesen | |
| 14.01. | Nexalin Technology, Inc.: Published Peer-Reviewed Study Demonstrates Nexalin's DIFS Neurostimulation Improves Attention and Normalizes Brain Activity in Patients with ADHD | 1 | GlobeNewswire (USA) | ||
| 05.12.25 | Nexalin Technology, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 03.12.25 | Nexalin erzielt Fortschritt bei FDA-Zulassung für Alzheimer-Gerät | 2 | Investing.com Deutsch |
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 21,280 | +1,48 % | Alignment Healthcare (ALHC) Soars 16% on Medicare Reimbursement Hike | ||
| PROGYNY | 17,170 | +1,18 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ADAPTHEALTH | 12,770 | +3,65 % | AdaptHealth refinances $1.1B senior secured credit facility | ||
| BRIGHTSPRING HEALTH SERVICES | 46,040 | -0,04 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita | LOUISVILLE, Ky., March 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based pharmacy and... ► Artikel lesen | |
| HEARTFLOW | 29,020 | +5,68 % | Heartflow, Inc.: Heartflow Files Patent Infringement Lawsuit Against Cleerly | MOUNTAIN VIEW, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it has filed... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 19,740 | +5,34 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner | ||
| BETA BIONICS | 11,815 | +11,04 % | Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| LEMAITRE VASCULAR | 100,00 | 0,00 % | LeMaitre Vascular, Inc.: LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026 | ||
| PRIVIA HEALTH GROUP | 23,120 | +0,43 % | What Makes Privia Health (PRVA) One of the Best Mid-Cap Growth Stocks to Invest in | ||
| STRAUMANN | 95,50 | -0,10 % | Straumann Holding AG: Einladung: Straumann Group - Umsatzzahlen 1. Quartal 2026 Webcast | Straumann Holding AG
/ Schlagwort(e): Quartalsergebnis
Einladung: Straumann Group - Umsatzzahlen 1. Quartal 2026 Webcast
08.04.2026 / 11:00 CET/CEST
Datum: Mittwoch... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,510 | +0,70 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 6,290 | +1,78 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Notification regarding unquoted securities - AVR | ||
| SIGHT SCIENCES | 3,820 | +3,52 % | Sight Sciences, Inc.: Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing... ► Artikel lesen | |
| CERIBELL | 19,550 | +2,25 % | Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results | SUNNYVALE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 3,385 | +2,89 % | Oncology Institute reports $1.8M Medicare savings in latest period |
Das Unternehmen NEXALIN TECHNOLOGY INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -1,19 % bei einem Aktienkurs von 0,425 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEXALIN TECHNOLOGY INC finden Sie auf Wallstreet Online.